Visen Pharmaceuticals Secures Hainan Approval for Palopegteriparatide
CompanyDrug

Visen Pharmaceuticals Secures Hainan Approval for Palopegteriparatide

CStone Pharmaceuticals Launches CS2009 Phase II Trial in Australia
CompanyDrug

Stone Pharmaceuticals Launches CS2009 Phase II Trial in Australia

Nanjing Leads Biolabs Secures FDA IND for LBL‑047, a First‑In‑Class Bispecific Fusion Protein
CompanyDrug

Nanjing Leads Biolabs Secures FDA IND for LBL‑047, a First‑In‑Class Bispecific Fusion Protein

China’s Insilico, Mabwell, and Chemexpress Forge AI‑Driven ADC Collaboration
CompanyDeals

China’s Insilico, Mabwell, and Chemexpress Forge AI‑Driven ADC Collaboration

NHSA Completes 2025 Drug Negotiation Review; CAR‑T Therapies Clear the Hurdle
Policy / Regulatory

NHSA Completes 2025 Drug Negotiation Review; CAR‑T Therapies Clear the Hurdle

Shenzhen Salubris Submits NMPA NDA for SAL003, a Once‑Monthly Anti‑PCSK9 Biologic
CompanyDrug

Shenzhen Salubris Submits NMPA NDA for SAL003, a Once‑Monthly Anti‑PCSK9 Biologic

Biogen Acquires Alcyone Therapeutics to Drive ThecaFlex DRx Implant Development
CompanyDeals

Biogen Acquires Alcyone Therapeutics to Drive ThecaFlex DRx Implant Development

Henlius Organon Secure EU Marketing Approval for BILDYOS and BILPREVDA Denosumab Biosimilars
CompanyDrug

Henlius Organon Secure EU Marketing Approval for BILDYOS and BILPREVDA Denosumab Biosimilars

Innovent Secures 2nd NMPA Approval for Mazdutide – First Dual GLP‑1/GCGR Therapy for Type 2 Diabetes
CompanyDrug

Innovent Secures 2nd NMPA Approval for Mazdutide – First Dual GLP‑1/GCGR Therapy for Type 2 Diabetes

AusperBio Secures $63 Million Series B2 Financing to Propel AHB‑137 Development
CompanyDeals

AusperBio Secures $63 Million Series B2 Financing to Propel AHB‑137 Development

Pfizer and Arvinas Pass Commercial Rights of Vepdegestrant to Third Party
CompanyDeals

Pfizer and Arvinas Pass Commercial Rights of Vepdegestrant to Third Party

Guangdong Taienkang Secures NMPA Approval for Safinamide Generic
CompanyDrug

Guangdong Taienkang Secures NMPA Approval for Safinamide Generic